Thu, August 10, 2023
Wed, August 9, 2023
Tue, August 8, 2023

Matthew Caufield Reiterated (UBX) at Strong Buy and Held Target at $10 on, Aug 9th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. g-buy-and-held-target-at-10-on-aug-9th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Matthew Caufield of HC Wainwright & Co., Reiterated "Unity Biotechnology, Inc." (UBX) at Strong Buy and Held Target at $10 on, Aug 9th, 2023.

Matthew has made no other calls on UBX in the last 4 months.



There are 3 other peers that have a rating on UBX. Out of the 3 peers that are also analyzing UBX, 1 agrees with Matthew's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Andreas Argyrides of "Wedbush" Downgraded from Buy to Hold and Decreased Target to $2 on, Monday, June 26th, 2023


These are the ratings of the 2 analyists that currently disagree with Matthew


  • Dylan Dupuis of "Roth MKM" Initiated at Strong Buy and Held Target at $10 on, Wednesday, May 31st, 2023
  • Yigal Nochomovitz of "Citigroup" Maintained at Strong Buy with Increased Target to $6 on, Friday, May 26th, 2023

Publication Contributing Sources